After more than two years preparation Dr Nick Lyons and Dr Georgina Limon-Vega from The Pirbright Institute commenced a Crimean-Congo haemorrhagic fever (CCHF) vaccine trial in Bulgaria on 5 March 2019. If successful, this could pave the way for the first licensed vaccine that is demonstrated to be effective against this infection.
News from April 2019
A collaborative study led by The Pirbright Institute and Imperial College London has identified variations in the genes of chicken antiviral proteins called interferon-induced transmembrane proteins (IFITMs) which could have an impact on their ability to fight viral infections. This is the first study to look at the natural genetic variation of IFITM genes across breeds, which could be used to inform commercial poultry breeding.
The Pirbright Institute has announced the appointment of a new Chair of the Trustee Board and several new Trustees. Professor John Stephenson steps up from his position on the Trustee Board to take over as Chair of the Trustee Board from Professor Quintin McKellar CBE, who is stepping down.